Top Stories

Vagefi will focus on healthcare, with an emphasis on healthcare technology, leveraging his prior experience with such companies as Qualifacts-Credible and Altruista.

Houlihan Lokey advises the Stamford, Connecticut-based medical communications business on its pending sale.

Harris Williams is providing financial advice to the company, which partners with not-for-profit health systems to manage the discharge of patients.

A Harris Williams-run sale process enters its second round for the wound care company, which expects 2021 EBITDA to approach $100m.

The nutrition supplement company hit the auction block late last year, but the Centerview-run process has yet to produce a buyer, according to sources.

Buoyed by an aggressive M&A playbook, Summit under exiting investor CI Capital witnessed a revenue CAGR of 43% alongside EBITDA CAGR of 64%, a source said.

PT assets have shown there are multiple ways to grow; demographic trends are favorable with an aging population; musculoskeletal issues abound; and the future consolidation opportunity remains vast, sources said.

Co-head of Vista’s $1bn Endeavor Fund, Rachel Arnold, talks about valuation dynamics and ways to bring in and retain diverse talent.

The PE firm snapped up refrigeration equipment providers QBD and Minus Forty at a $230m valuation, or just over 7x EBITDA multiple.

The former MBF Healthcare investor joins Regal HCP just weeks after the healthcare-focused PE firm produced big outcomes with partial exits of Thriveworks and Dental365.